Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiota Tsitsi

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|January 27, 2024
Retinitis pigmentosa and pes cavus in PHARC-polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract-syndrome in a 62-year-old manGert Cypers, Panagiota Tsitsi
NPJ Parkinson'S Disease|July 3, 2019
Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson's diseaseJosefine Waldthaler, Panagiota Tsitsi, Per Svenningsson
JAMA Neurology|April 22, 2024
A 24-Year-Old Man With Spastic Ataxia and HypodontiaLissa Marien, Panagiota Tsitsi, Gert Cypers
CNS Drugs|January 29, 2019
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related PathwaysHolly Green, Panagiota Tsitsi, Ioanna Markaki, et al.
JIMD Reports|January 14, 2022
Neurocognitive profile of adults with the Norrbottnian type of Gaucher diseasePanagiota Tsitsi, Ioanna Markaki, Josefine Waldthaler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2018
Eye movements during reading in Parkinson's disease: A pilot studyJosefine Waldthaler, Panagiota Tsitsi, Gustaf Öqvist Seimyr, et al.
Movement Disorders Clinical Practice|April 18, 2023
Reading Alterations in Parkinson's Disease Indicate Worse Cognitive StatusPanagiota Tsitsi, Mattias Nilsson, Gustaf Öqvist Seimyr, et al.
Neuropsychology|April 4, 2022
Changes in emotion processing in early Parkinson's disease reflect disease progressionAllison Eriksson, Panagiota Tsitsi, Mikkel C Vinding, et al.
NPJ Parkinson'S Disease|December 12, 2018
Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trialPer Svenningsson, Anders Johansson, Dag Nyholm, et al.
Parkinsonism & Related Disorders|February 5, 2023
Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal SyndromeShervin Khosousi, Abdul Hye, Latha Velayudhan, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|January 27, 2024
Retinitis pigmentosa and pes cavus in PHARC-polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract-syndrome in a 62-year-old manGert Cypers, Panagiota Tsitsi
NPJ Parkinson'S Disease|July 3, 2019
Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson's diseaseJosefine Waldthaler, Panagiota Tsitsi, Per Svenningsson
JAMA Neurology|April 22, 2024
A 24-Year-Old Man With Spastic Ataxia and HypodontiaLissa Marien, Panagiota Tsitsi, Gert Cypers
CNS Drugs|January 29, 2019
Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related PathwaysHolly Green, Panagiota Tsitsi, Ioanna Markaki, et al.
JIMD Reports|January 14, 2022
Neurocognitive profile of adults with the Norrbottnian type of Gaucher diseasePanagiota Tsitsi, Ioanna Markaki, Josefine Waldthaler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 10, 2018
Eye movements during reading in Parkinson's disease: A pilot studyJosefine Waldthaler, Panagiota Tsitsi, Gustaf Öqvist Seimyr, et al.
Movement Disorders Clinical Practice|April 18, 2023
Reading Alterations in Parkinson's Disease Indicate Worse Cognitive StatusPanagiota Tsitsi, Mattias Nilsson, Gustaf Öqvist Seimyr, et al.
Neuropsychology|April 4, 2022
Changes in emotion processing in early Parkinson's disease reflect disease progressionAllison Eriksson, Panagiota Tsitsi, Mikkel C Vinding, et al.
NPJ Parkinson'S Disease|December 12, 2018
Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trialPer Svenningsson, Anders Johansson, Dag Nyholm, et al.
Parkinsonism & Related Disorders|February 5, 2023
Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal SyndromeShervin Khosousi, Abdul Hye, Latha Velayudhan, et al.
Pageof 3